Navigation Links
Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
Date:5/25/2011

for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control.  QIAGEN's assay technologies include multiple companion diagnostics that are co-developed with its pharmaceutical partners. Companion diagnostics are used to predict in advance which patients are most likely to benefit from a particular therapy.

QIAGEN's portfolio encompasses the therascreen® EGFR RGQ PCR Kit (CE-IVD) available in Europe, as well as a broad panel of other biomarkers including KRAS, PI3K, BRAF for Research Use Only (RUO) or CE-IVD. The QIAGEN EGFR test is not available for routine clinical diagnostic use in the United States.

QIAGEN employs nearly 3,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.QIAGEN.com.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operatio
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... LONDON, Sept. 3, 2015 With a population ... largest country and therefore also its single largest potential ... years, China has led all major world economies in ... health expenditures, and government health expenditures. As an in ... developed markets of the United States, western European countries, ...
(Date:9/3/2015)... NEW YORK , Sept. 3,  2015 ... organs are human-made bio-artificial devices, which are ... or support natural organs. These include artificial ... materials such as polymers (polyurethane, polysulfone, and ... used to develop artificial organs. These organs ...
(Date:9/3/2015)... Sept. 3, 2015 About dry eye syndrome ... due to deficient tear production or quick tear evaporation ... two types: aqueous tear deficient dry eye and evaporative ... glands do not produce enough tears, whereas meibomian gland ... lipids to slow tear evaporation and maintain tear stability. ...
Breaking Medicine Technology:IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2
... (NYSE: GSK ) today announced that it has reached ... to join the USPTO,s motion to dismiss its litigation over ... Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. ... Office). GSK and the USPTO will file a joint ...
... , THE WOODLANDS, Texas, Oct. 8 Lexicon Pharmaceuticals, ... a public offering of 33,333,333 shares of its common stock ... offered through the underwriters and 13,439,257 shares are being offered ... shares are being offered by Lexicon pursuant to an effective ...
Cached Medicine Technology:GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations 2Lexicon Announces Pricing of Common Stock in Public Offering 2Lexicon Announces Pricing of Common Stock in Public Offering 3
(Date:9/3/2015)... BELLINGHAM, WA (PRWEB) , ... September 03, 2015 ... ... new memory care community to be situated at 4400 Columbine Drive in Bellingham, ... in late 2016, and has been carefully designed to serve up to 80 ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... of graduated compression garments. However, graduated compression garments are an effective solution for ... lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS for a ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice columnist, professional life ... debut book, “Stop Wasting Your Time Blaming Others for Your Life.” , Released ... to overcoming life’s obstacles by taking full responsibility for one’s life shares 15 ...
(Date:9/3/2015)... , ... September 03, 2015 , ... The Linda ... control, the surface of a comet, the IceCube observatory at the South Pole, and ... , The Fall Lecture Series for the world's foremost independently funded research library ...
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. Smith, the only ... lead a national chief executive officer recruitment for Melissa Memorial Hospital ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
Breaking Medicine News(10 mins):Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... , , CHERRY HILL, N.J., Aug. ... it will issue a shareholder newsletter on September 1, 2009. Additionally, ... September 16th, Chicago on September 17th, and Los Angeles on September ... or before September 7, 2009. , , "We ...
... DES MOINES, Iowa, Aug. 25 The Graham Group, ... Plaza II, a three-story, 70,000 square-foot medical office building serving Tucson, ... located on the campus of Carondelet St. Mary,s Hospital, a member ... offices currently include the Carondelet Medical Group, a large family practice ...
... , WILMINGTON, Del., Aug. 25 ... to FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) programs for ... for the equally mandatory program evaluations beginning just 1-1/2 years ... That warning has been issued by risk management ...
... at The University of Nottingham and Health Protection Agency East ... virus after being commissioned as part of the government,s response ... how long someone is contagious for and advise on a ... led by Professor Jonathan Nguyen Van Tam of the University ...
... CITY, Ohio, Aug. 25 One month ago, July 20, 2009, ... to bicycle through all 48 states in the continental U.S. in 48 days, ... City, Ohio, Nagle now has passed well beyond the halfway point on his ... , In addition to eyeing a Guinness World Record with his ...
... WASHINGTON, Aug. 25 Covenant ... $4.5 million to resolve allegations that it violated the False Claims Act, ... This settlement resolves allegations ... five physicians that violated the Stark Law. The Stark Law prohibits ...
Cached Medicine News:Health News:Nuvilex to Issue Positive Shareholder Newsletter 2Health News:Nuvilex to Issue Positive Shareholder Newsletter 3Health News:Nuvilex to Issue Positive Shareholder Newsletter 4Health News:Nuvilex to Issue Positive Shareholder Newsletter 5Health News:Nottingham scientists commissioned for urgent swine flu research 2Health News:College Student's '48 States in 48 Days' Bike Ride Moves Well Beyond the Halfway Point 2Health News:Covenant Medical Center to Pay U.S. $4.5 Million to Resolve False Claims Act Allegations 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: